Q8NI51

PTMD Annotation Information


※ Protein Information

Tag Content
UniProt Accession CTCFL_HUMAN; Q8NI51;
Entrez ID 140690
GenBank Protein ID NM_001269040.1; NM_001269041.1; NM_001269042.1; NM_001269043.1; NM_001269044.1; NM_001269045.1; NM_001269046.1; NM_001269047.1; NM_001269048.1; NM_001269049.1; NM_001269050.1; NM_001269051.1; NM_001269052.1; NM_001269054.1; NM_001269055.1; NM_080618.3;
GenBank Nucleotide ID NP_001255969.1; NP_001255970.1; NP_001255971.1; NP_001255972.1; NP_001255973.1; NP_001255974.1; NP_001255975.1; NP_001255976.1; NP_001255977.1; NP_001255978.1; NP_001255979.1; NP_001255980.1; NP_001255981.1; NP_001255983.1; NP_001255984.1; NP_542185.2;
Protein Name Transcriptional repressor CTCFL (Brother of the regulator of imprinted sites) (CCCTC-binding factor) (CTCF paralog) (CTCF-like protein) (Cancer/testis antigen 27) (CT27) (Zinc finger protein CTCF-T)
Gene Name CTCFL; BORIS
Organism Homo sapiens
NCBI Taxa ID 9606
Functional DescriptionTestis-specific DNA binding protein responsible for insulator function, nuclear architecture and transcriptional control, which probably acts by recruiting epigenetic chromatin modifiers. Plays a key role in gene imprinting in male germline, by participating in the establishment of differential methylation at the IGF2/H19 imprinted control region (ICR). Directly binds the unmethylated H19 ICR and recruits the PRMT7 methyltransferase, leading to methylate histone H4 'Arg-3' to form H4R3sme2. This probably leads to recruit de novo DNA methyltransferases at these sites (By similarity). Seems to act as tumor suppressor. In association with DNMT1 and DNMT3B, involved in activation of BAG1 gene expression by binding to its promoter. Required for dimethylation of H3 lysine 4 (H3K4me2) of MYC and BRCA1 promoters.
Sequence
(Fasta)
MAATEISVLS EQFTKIKELE LMPEKGLKEE EKDGVCREKD HRSPSELEAE RTSGAFQDSV 60
LEEEVELVLA PSEESEKYIL TLQTVHFTSE AVELQDMSLL SIQQQEGVQV VVQQPGPGLL 120
WLEEGPRQSL QQCVAISIQQ ELYSPQEMEV LQFHALEENV MVASEDSKLA VSLAETTGLI 180
KLEEEQEKNQ LLAERTKEQL FFVETMSGDE RSDEIVLTVS NSNVEEQEDQ PTAGQADAEK 240
AKSTKNQRKT KGAKGTFHCD VCMFTSSRMS SFNRHMKTHT SEKPHLCHLC LKTFRTVTLL 300
RNHVNTHTGT RPYKCNDCNM AFVTSGELVR HRRYKHTHEK PFKCSMCKYA SVEASKLKRH 360
VRSHTGERPF QCCQCSYASR DTYKLKRHMR THSGEKPYEC HICHTRFTQS GTMKIHILQK 420
HGENVPKYQC PHCATIIARK SDLRVHMRNL HAYSAAELKC RYCSAVFHER YALIQHQKTH 480
KNEKRFKCKH CSYACKQERH MTAHIRTHTG EKPFTCLSCN KCFRQKQLLN AHFRKYHDAN 540
FIPTVYKCSK CGKGFSRWIN LHRHSEKCGS GEAKSAASGK GRRTRKRKQT ILKEATKGQK 600
EAAKGWKEAA NGDEAAAEEA STTKGEQFPG EMFPVACRET TARVKEEVDE GVTCEMLLNT 660
MDK 664

※ PTM-Disease Association

NumPTMDiseaseCell TypeTypePTM SitePMID
1MethylationBreast cancer/tumor/carcinomaU3917730; 24649078
[Reference]: hese results suggested that estrogens may modulate?CTCF?expression, although there was no apparent association between ERs and?CTCFL.

※ Disease Cross-ref Annotation

DatabaseAnnotation
GWASdb
(count: 4)
rs2209885; Suicide attempts in bipolar disorder; bipolar disorder
rs11700100; Response to cytadine analogues (cytosine arabinoside); cancer
rs12625924; Alzheimer's disease; Alzheimer's disease
rs6025606; Smoking cessation; nicotine dependence

※ PTM Sites

PTM Modification Sites
Phosphorylation
(count: 13)
(view all)
256       KTKGAKGTFHCDVCM     dbPAF
270       MFTSSRMSSFNRHMK     dbPAF
271       FTSSRMSSFNRHMKT     dbPAF
393       KRHMRTHSGEKPYEC     dbPAF
410       CHTRFTQSGTMKIHI     dbPAF
43        CREKDHRSPSELEAE     dbPAF